Florida Cancer Specialists physician co-authors study looking at treatment regimen for low-grade lymphoma
2018-03-04
Dr. Andrew Lipman, who practices at Florida Cancer Specialists (FCS) in Bonita Springs and Naples West offices, was a co-author of a research paper evaluating the safety and efficacy of combining three drug agents – bendamustine, bortezomib and rituximab (BBR) – in patients with previously untreated low-grade lymphoma. Published January 2018 in the British Journal of Haematology,Continue Reading
